Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:1294 |
| Name | vulva carcinoma |
| Definition | A vulva cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells. |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Path | disease disease of cellular proliferation cancer organ system cancer reproductive organ cancer female reproductive organ cancer vulva cancer vulva carcinoma |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02488759 | Phase Ib/II | Nivolumab | A Study to Investigate the Safety and Efficacy of Nivolumab in Virus-associated Tumors (CheckMate358) | Completed | USA | NLD | GBR | FRA | ESP | DEU | BEL | 4 |
| NCT02628067 | Phase II | Pembrolizumab | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | Active, not recruiting | 0 | |
| NCT03418480 | Phase Ib/II | BNT113 | HPV Anti-CD40 RNA Vaccine (HARE-40) | Completed | GBR | 0 |
| NCT03517488 | Phase I | XmAb20717 | A Study of XmAb20717 in Subjects With Selected Advanced Solid Tumors (DUET-2) | Completed | USA | 0 |
| NCT06677190 | Phase II | Belzutifan | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | Recruiting | USA | 0 |
| NCT06686043 | Phase II | Imiquimod + Metformin + Recombinant human papillomavirus 9-valent vaccine | HPV Vaccine, Imiquimod, and Metformin Combination Trial (HPV-VIM) | Recruiting | USA | 0 |